Gamma Healthcare, Inc. v. United States Department of Health and Human Services

CourtDistrict Court, W.D. Missouri
DecidedOctober 28, 2020
Docket6:20-cv-03337
StatusUnknown

This text of Gamma Healthcare, Inc. v. United States Department of Health and Human Services (Gamma Healthcare, Inc. v. United States Department of Health and Human Services) is published on Counsel Stack Legal Research, covering District Court, W.D. Missouri primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Gamma Healthcare, Inc. v. United States Department of Health and Human Services, (W.D. Mo. 2020).

Opinion

IN THE UNITED STATES DISTRICT COURT FOR THE WESTERN DISTRICT OF MISSOURI

GAMMA HEALTHCARE, INC., ) Plaintiff, ) ) v. ) ) ALEX AZAR, in his official capacity ) as Secretary, United States Department ) of Health and Human Services, ) Case No. 6:20-CV-033337-MDH ) SEEMA VERMA, in her official ) capacity as Acting Administrator for the ) Center of Medicare and Medicaid Services, ) AND ) ) JEFF KAHRS, Deputy Regional Administrator ) for (Region 7) the Center for Medicare ) and Medicaid Services. ) ) Defendants. )

ORDER ON EMERGENCY MOTION FOR TEMPORARY RESTRAINING ORDER AND PRELIMINARY AND PERMANENT INJUNCTIVE RELIEF

Before the Court is Plaintiff Gamma Healthcare, Inc.’s Emergency Motion for Temporary Restraining Order. (Doc. 3). Plaintiff requests the Court issue a TRO pursuant to Rule 65(c) prohibiting Defendants from suspending and revoking GHC’s CLIA Certificate until such time as the Court is able to determine whether the preliminary injunction should remain in effect as a permanent injunction pending Plaintiff’s opportunity to exhaust its administrative appeal remedies. On October 26, 2020, the Court held a hearing regarding the pending motions. The Court then granted the parties additional time to submit supplemental briefing on the issues presented at the hearing. The parties have now fully briefed the issues and the matter is ripe for review. For the reasons set forth herein, Plaintiff’s Motion is DENIED. BACKGROUND Plaintiff operates clinical laboratories located in Springfield, Missouri and Poplar Bluff, Missouri, which provide a variety of medical testing services. (Doc. 1). Until the events giving rise to this lawsuit, both labs operated under Clinical Laboratory Improvement Amendments (“CLIA”) certificates. (Doc. 12, 5). Defendants suspended Plaintiff’s federal authority to operate as clinical

labs, effective October 26, 2020, pursuant to the Defendants’ authority to suspend Plaintiff’s lab certificates in advance of an administrative hearing. 42 U.S.C. § 263a(i) (Doc. 12, 1). Plaintiff’s Complaint raises the following claims: Injunctive Relief based on allegations of due process violations; Violation of Equal Protection Guarantees of the Fourteenth Amendment; and Violation of Due Process Guarantees of the Fourteenth Amendment. “Labs like [Plaintiff] must meet certain federal standards in order to be certified to conduct diagnostic tests on human specimens (blood, tissue, and the like), and to receive Medicare or Medicaid reimbursement for their services. These standards are embodied in the Clinical Laboratory Improvement Amendments of 1988 (‘CLIA’ or ‘the Act’) and its implementing

regulations. See 42 U.S.C. § [263a]; 42 C.F.R. Part 493.” Wade Pediatrics v. Dep’t of Health & Human Servs., 567 F.3d 1202, 1203 (10th Cir. 2009). A lab’s compliance with these standards is memorialized in a “CLIA certificate,” which is subject to periodic reconsideration. Additionally, the Secretary of Health and Human Services’ designee may, on an announced or unannounced basis, enter and inspect any certified lab to determine whether the lab is, in fact, compliance with federal standards. 42 U.S.C. § 263a(g). If the Secretary determines the lab is out of compliance, the Secretary may impose sanctions. 42 U.S.C. §§ 263a(h)–(i). Sanctions may be mild or severe, including suspension or revocation of a lab’s federal certification. Id. Generally, the Secretary cannot suspend a lab’s federal certification before an administrative hearing, assuming the lab wishes to contest the suspension. 42 U.S.C. § 263a(i). However, if the Secretary determines that a lab’s failure to comply with federal standards presents an imminent and serious risk to human health, the Secretary may suspend the lab’s certification prior to a hearing. 42 U.S.C. § 263a(i)(2). Federal regulations govern how the Secretary’s designees go about the important work of assessing which labs meet federal standards and which labs need to be pulled into compliance. 42

C.F.R. Part 493. Inevitably, most labs will fail to comply in some material way, but not all failures merit the same response. Federal regulations generally permit two categories of civil sanctions: (1) “principal sanctions,” which are suspension, limitation, or revocation of the lab’s certification; or (2) “alternative sanctions,” which are government-directed plans of correction, state onsite monitoring, or civil money penalties. 42 C.F.R. § 493.1806. The two categories of sanctions get meted out against varying levels and patterns of noncompliance, and federal regulations generally guide the considerations in determining appropriate sanctions. 42 C.F.R. § 493.1804. In cases of extreme and repetitive noncompliance, the regulations permit the Secretary to suspend a lab’s certification prior to a hearing, on a mere five days’ notice. 42 C.F.R. §§

493.1812(b); 493.1840(d)(2). Cf. 42 U.S.C. § 263a(i)(2). If a lab’s deficiencies pose “immediate jeopardy”—imminent and serious risk to human health and significant hazard to the public health—the lab must take immediate action. 42 C.F.R. § 493.1812(a). If the findings of a revisit to the lab indicate that the lab has not eliminated the imminent and serious risk to human health, the Centers for Medicare & Medicaid Services (CMS) suspends or limits the lab’s federal certification. 42 C.F.R. § 493.1812(b). CMS must provide at least five days’ notice, but it need not suspend a lab’s federal certification in advance of a hearing. 42 C.F.R. §§ 493.1812(b), 493.1840(d)(2). STANDARD Before the Court can analyze the issues raised in Plaintiff’s Motion for a Preliminary Injunction, the Court must first analyze whether it has jurisdiction over the claims raised in the Complaint. “The burden of establishing that federal jurisdiction exists ‘rests upon the party asserting jurisdiction.’” Midland Psychiatric Assocs., Inc. v. United States, 145 F.3d 1000, 1003

(8th Cir. 1998) (internal citations omitted). A court must dismiss an action over which it lacks subject-matter jurisdiction. Degnan v. Sebelius, 959 F. Supp. 2d 1190, 1192 - 93 (D. Minn. 2013), aff'd sub nom. Degnan v. Burwell, 765 F.3d 805 (8th Cir. 2014). DISCUSSION The Court generally does not have federal question jurisdiction over any claim for Medicare or Medicaid payment (or nonpayment). Cf. 42 U.S.C.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Mathews v. Eldridge
424 U.S. 319 (Supreme Court, 1976)
Heckler v. Ringer
466 U.S. 602 (Supreme Court, 1984)
Cleveland Board of Education v. Loudermill
470 U.S. 532 (Supreme Court, 1985)
PLANNED PARENT. MN, N. DAKOTA, S. DAKOTA v. Rounds
530 F.3d 724 (Eighth Circuit, 2008)
Rockhill Care Center, Inc. v. Harris
502 F. Supp. 1227 (W.D. Missouri, 1980)
Key Medical Supply, Inc. v. Kathleen Sebelius
764 F.3d 955 (Eighth Circuit, 2014)
Charles Degnan v. Kathleen Sebelius
765 F.3d 805 (Eighth Circuit, 2014)
Family Rehab., Inc. v. Azar
886 F.3d 496 (Fifth Circuit, 2018)
Degnan v. Sebelius
959 F. Supp. 2d 1190 (D. Minnesota, 2013)
Koerpel v. Heckler
797 F.2d 858 (Tenth Circuit, 1986)

Cite This Page — Counsel Stack

Bluebook (online)
Gamma Healthcare, Inc. v. United States Department of Health and Human Services, Counsel Stack Legal Research, https://law.counselstack.com/opinion/gamma-healthcare-inc-v-united-states-department-of-health-and-human-mowd-2020.